In the TME, TGFβ is known as a key factor that induces trans-differentiation of cancer resident fibroblasts into αSMA-positive myofibroblasts, such as cancer-associated fibroblasts (CAFs), and promotes tumor progression. Here, ACTA1 is linked to cancer.